AAME vs BENF
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
AAME's Piotroski F-Score of 4/9 indicates weak financial health, signaling potential operational inefficiencies and limited profitability sustainability. The absence of an Altman Z-Score raises concern about default risk, particularly given the company's small size and high leverage relative to peers. While the stock trades at a significant discount to its Graham Number ($5.27) and intrinsic value ($1.61), suggesting undervaluation, this is offset by stagnant earnings growth, poor technical momentum, and lack of analyst coverage. The 20.8% revenue growth is encouraging but unconfirmed by earnings data, and the 1Y return of +100.9% may reflect speculative momentum rather than fundamentals.
The company exhibits severe financial distress with a Piotroski F-Score of just 1/9, indicating very weak fundamental health. Negative profitability metrics, including a Price/Book of -0.02 and ROE of -551.08%, reflect deep structural issues. Despite a bullish analyst target price of $16.00, the stock's operational instability, extreme earnings volatility, and lack of reliable financial data undermine any valuation confidence. The technical trend is bearish, and recent price swings suggest speculative trading rather than fundamental recovery.
Compare Another Pair
Related Comparisons
AAME vs BENF: Head-to-Head Comparison
This page compares Atlantic American Corporation (AAME) and Beneficient (BENF) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.